Archive for 2010

Synthetic Biology: What's the Agenda?

The Center for Policy on Emerging Technologies, where I am on the board of directors, is hosting an Emerging Technologies Roundtable: August 13, 2010 – “Synthetic Biology: What’s the Agenda?” Synthetic biology has hit the headlines yet again. The J. Craig Venter Institute’s recent dramatic announcement led to a replay of President Clinton’s urgent request […]



Synthetic Biology: What’s the Agenda?

The Center for Policy on Emerging Technologies, where I am on the board of directors, is hosting an Emerging Technologies Roundtable: August 13, 2010 – “Synthetic Biology: What’s the Agenda?” Synthetic biology has hit the headlines yet again. The J. Craig Venter Institute’s recent dramatic announcement led to a replay of President Clinton’s urgent request […]



Biotechnology and Business Publishing Opportunities: Blog posts, Journal Articles, Books, and Magazines

Do you have an idea for an article, a blog post, a book, or a magazine article? In addition to publishing BiotechBlog, I also manage other publishing opportunities. Check out my publishing opportunities page for an overview of opportunities.



Journal of Commercial Biotechnology — July 2010 issue now available

The July 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 3 Editorial Increasing clarity PDF Yali Friedman Commentary Personalized medicine and oncology: A commentary and key questions PDF Robert Freeman Articles Market access – An essential investment […]



Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business

Now available, a new textbook from Logos Press: Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business Available from Amazon.com and bookstores everywhere. Mark J. Ahn, Michael A. Alvarez, Arlen D. Meyers, Anne S. York, editors Foreword by G. Steven Burrill First Edition, July 2010 Perfect Bound, 416 pages, […]



Biotech U — Free online biotechnology course

I’ve decided to open up Biotech U and make the comprehensive biotechnology industry overview course free for the month of July. The course is derived from my textbook, Building Biotechnology, and covers the following topics: Biotechnology Industry Introduction The Development of Biotechnology Preface: The Science of Biotechnology Introduction to Molecular Biology Drug Development Tools and […]



Drug Patent Expirations in July 2010

Drug Patent Expirations in July 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration PROAIR HFA Teva Global albuterol sulfate 5,695,743 Jul 6, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,225,183 Jul 6, 2010 PROVENTIL-HFA 3m albuterol sulfate 5,439,670 Jul 6, 2010 XOPENEX HFA Sepracor levalbuterol tartrate 5,695,743 Jul […]



Biosimilar drugs to gain greater priority as decade progresses

This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs to gain greater priority as decade progresses The Patient Protection and Affordable Care Act will heighten the degree of competition in the field of biotech drugs, a fast growing area of drug therapy that is […]



Biotechnology Management Papers, 2010

These papers are from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: If You Build It, Will They Come? Derek Francis Profitability […]



Profitability and Orphans: The Role of Price and Incentives in Four Different Markets

This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Profitability and Orphans: The Role of Price […]



%d bloggers like this: